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15

Abstract

16

Purpose: Chronic inflammation plays a role in the pathogenesis of age-related renal disease and the diet can

17

moderate systemic inflammation. The primary objective of this study was to examine the associations between a

18

dietary inflammatory index (DII®) score and renal function, the trajectory of renal function decline, and renal

19

disease-related hospitalizations and/or mortality over 10 years.

20

Methods: The study was conducted in 1422 Western Australian women without prevalent chronic kidney

21

disease and aged ≥ 70 years. Baseline dietary data, obtained from a validated food frequency questionnaire,

22

were used to calculate a DII score for each individual.

23

Results: In this cohort the mean [range] DII score was 0.19 [-6.14 – 6.39]. A higher DII score was associated

24

with poorer renal function and a greater renal function decline over 10 years; after multivariable adjustments a

25

one-unit higher DII score was associated with a 0.55 mL/min/1.73m 2 lower eGFR at baseline (p=0.01), and a

26

0.06 mL/min/1.73m2 greater annual decline in eGFR over 10 years (p=0.05). Restricted cubic splines provide

27

evidence of a non-linear association between baseline DII score and risk of a renal disease-related event.

28

Compared to participants in the lowest quintile, those in the highest quintile of DII score were at a higher risk of

29

experiencing a renal disease-related event (adjusted HR: 2.06, 95% CI: 0.97, 4.37).

30

Conclusion: Recommending an increased consumption of foods with a higher anti-inflammatory potential could

31

form part of a multifaceted approach to reduce the risk of renal disease through diet and lifestyle changes.

3

32

Introduction

33

Chronic kidney disease (CKD) has emerged as a major public health concern and significant driver of healthcare

34

expenditures [1,2]. The incidence of CKD is steadily increasing, with a global prevalence of up to 13% [3].

35

Although a substantial proportion of older individuals in the general population have stage 2-3 CKD, individuals

36

exhibiting a rapid decline in kidney function have the greatest risk of adverse health outcomes [4]. It has been

37

suggested that chronic inflammation may play a critical role in the pathogenesis of age-related CKD and/or

38

kidney function decline [1,5,6], suggesting that attenuation of an inflammatory response could potentially slow

39

renal decline and/or reduce the risk of CKD-related adverse outcomes.

40

Over the last decade, the role that diet plays in the regulation of systemic inflammation has become increasingly

41

apparent [7,8]. Epidemiological studies have shown that the intake of anti-inflammatory foods and nutrients,

42

primarily fruit, vegetables, fibre, omega-3 polyunsaturated fatty acids and vitamins, are associated with lower

43

serum levels of inflammatory biomarkers in persons at risk of developing CKD [9,6,10]. In contrast, pro-

44

inflammatory diets typically high in refined grains, full fat dairy, red meat, total fat, and saturated fat are

45

positively associated with higher levels of inflammatory biomarkers [11] and a higher incidence of CKD [12].

46

The literature-derived Dietary Inflammatory Index (DII®), based on 45 food parameters, is a suggested indicator

47

of the inflammatory potential of whole dietary patterns[13]. Previous research has proposed independent

48

associations between pro-inflammatory dietary patterns, indicated by high DII scores, and asthma[14],

49

cardiovascular disease[15], diabetes[16] and several cancers[17-20]. There is evidence that pro-inflammatory

50

diets are associated with systemic inflammation and reduced renal function[21]. However, associations between

51

DII, temporal change in renal function and renal disease-related adverse health outcomes, a large and growing

52

public health concern, remain unknown.

53

The aims of this study were to examine the associations between DII scores and renal function decline, and to

54

estimate the risk of renal disease-related hospitalization and/or mortality in a cohort of elderly women in

55

Australia. We hypothesized that, in a population of elderly women, a pro-inflammatory diet, characterized by a

56

higher DII score, would be associated with poorer baseline renal function and a more rapid renal function

57

decline as well as a higher risk of renal disease -related adverse health outcomes.

58
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59

Methods

60

Study Population

61

Participants were originally recruited in 1998 for a 5-year double-blind, randomised, controlled trial of oral

62

calcium supplements; the Calcium Intake Fracture Outcome Study (CAIFOS)[22]. Briefly, 1500 women aged

63

70 years and above were recruited from the Western Australian general population by mail using the Electoral

64

Roll. All participants in the study were ambulatory and had an expected survival beyond 5 years. Participants

65

received either 1.2 g of elemental calcium as calcium carbonate or a matching placebo daily. Following the

66

completion of the study, participants were followed for a further ten years as part of the Perth Longitudinal

67

Study of Aging in Women (PLSAW). Participants were similar to the age-matched general population in terms

68

of disease burden and pharmaceutical consumption[22]. The current study reports on 1,422 of the total 1,500

69

participants included in the PLSAW. As shown in Figure 1, participants who did not complete a food

70

frequency questionnaire (FFQ) at baseline and those with implausible energy intakes [<2,092 kJ/day

71

(<500kcal/day) and >14,644 kJ/day (>3,500kcal/day)] were excluded from the analysis (n=32), which is

72

consistent with other studies of this cohort[23,1]. Furthermore, all women with missing data (n=21) or a history

73

of prevalent renal disease at baseline were excluded (n=25).

74

All participants provided written informed consent for the study and for the follow up of electronic health

75

records. Ethics approval for the study was granted by The Human Ethics Committee of the University of

76

Western Australia (approval number 05/06/004/H50) and the Human Research Ethics Committee of the Western

77

Australian Department of Health (DOH HREC) approved the data linkage study (approval number #2009/24).

78

Dietary Assessment and Dietary Inflammatory Index Score

79

Diet was assessed at baseline (1998) using a semi-quantitative FFQ developed by the Cancer Council of

80

Victoria[24]. This FFQ has been validated against two 7-day weighed food records and was found to have

81

reasonable correlations for all nutrients, except retinol, due to the inclusion of liver in the weighed food records,

82

but not the FFQ[25]. Nutrient and energy intakes were estimated based on usual portion size and the frequency

83

of consumption[26]. The DII was intended for use in large epidemiological studies, with the intention of

84

examining whether DII scores are associated with risk of chronic diseases. A description of the development of

85

the DII is available elsewhere[13]. Briefly, the DII is based on 1,943 scientific articles published between 1950

86

and 2010 scoring 45 dietary components according to whether they increased (+1), decreased (-1) or had no

5

87

effect (0) on six inflammatory markers [interleukin (IL)-1 beta, IL-4, IL-6, IL-10, tumor necrosis factor-alpha,

88

and C-reactive protein). Articles were weighted by study characteristics; using these weighted values, a specific

89

inflammatory effect score was derived for each of the 45 food parameters. In the current study, the DII score

90

was calculated using the corresponding 32 food parameters available from the FFQ used in this cohort. To

91

calculate the DII score for each individual, the mean intake of each food parameter was standardized, converted

92

to centered proportions and then multiplied by the respective food parameter specific inflammatory effect score.

93

These parameter-specific DII scores were summed to create the overall DII score for each participant in the

94

study[13]. The 32 food parameters included in the DII score are shown in Supplemental Table 1. Higher DII

95

scores represent more pro-inflammatory dietary patterns, whereas lower DII scores represent more anti-

96

inflammatory dietary patterns.

97

Exposure

98

DII was both considered as a continuous variable and was categorized into quintiles: Q1 (-6.14, -1.72); Q2 (-

99

1.73, - 0.38); Q3 (-0.39, 0.76); Q4 (0.77, 2.13); Q5 (2.14, 6.39).

100

Study outcomes

101

The primary outcomes in this study were the association between DII score and renal function at baseline, 10-

102

year change in renal function, and renal disease-related hospitalizations and deaths (events) over the 10 years of

103

follow-up.

104

Renal function (eGFR)

105

Fasting blood samples for creatinine and cystatin C were collected at baseline (1998), 5 years (2003), and 10

106

years (2008), as described elsewhere[27,4]. Estimated glomerular filtration rate (eGFR) at each of these time

107

points was calculated from creatinine and cystatin C (CKD-EPI-creatinine and cystatin C) using the Chronic

108

Kidney Disease Epidemiology Collaboration (CKD-EPI) equation[28]. The annual rate of change in eGFR over

109

10 years of follow-up was estimated by calculating the slope of the line between eGFR measurements at two or,

110

when available, three time-points.

111

Biochemistry
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112

Plasma total L-homocysteine (tHcy) was measured using a Fluorescence Polarization Immuno-assay as

113

described previously [29]. High sensitivity C reactive protein (hs-CRP) was measured using a highly sensitive

114

latex immunoassay with a measurement range of 0.02 to 48.00 mg/dL (CRP Vario, Sentinel Diagnostics, Abbott

115

Diagnostics Europe, Milan, Italy).

116

10-year Renal Disease Hospitalisations and Mortality

117

Prevalent renal disease-related events were captured using a follow-up period of 18 years between 1980 and

118

1998 while incident events between 1998 and 2008 were retrieved from the Western Australian Data Linkage

119

System (WADLS) using the diagnoses codes from the International Classification of Diseases, Injuries and

120

Causes of Death Clinical Modification (ICD-9-CM)[30] and the International Statistical Classification of

121

Diseases and Related Health Problems, 10th Revision, Australian Modification (ICD-10-AM)[31]. WADLS is a

122

comprehensive, population-based linkage system connecting 40 years of data from over 30 health-related

123

datasets for Western Australian residents using ICD codes[32]. A renal disease event was defined as first-time

124

renal disease-related hospitalization or renal disease-related death. Codes used for identification of renal disease

125

hospitalizations included ICD-9-CM codes 580–583, ICD-10-AM codes N00–08, ICD-9-CM codes 593.3–

126

593.5, 593.7 and 590–591, ICD-10-AM codes N09–16, ICD-9-CM codes 584–586, ICD-10-AM codes N17–19,

127

ICD-9-CM code 403, and ICD-10-AM codes I12 in either the participant’s primary discharge diagnosis or

128

additional diagnoses fields. Renal disease-related death ICD codes included all available diagnostic information

129

that comprised Parts 1 and 2 of the death certificate. All diagnosis text fields from the death certificate were

130

used to ascertain the cause(s) of deaths where these data were not yet available from the WADLS.

131

Covariates

132

Baseline questionnaires were used to determine values for potential confounding variables including age, use of

133

antihypertensive medication, use of statins, use of NSAIDs for musculoskeletal pain, and current/previous

134

smoking. Smoking status was defined as non-smoker or ex-smoker/current smoker if a participant had ever

135

consumed more than 1 cigarette per day for more than 3 months during their lifetime. Weight (kg) was

136

measured using digital scales, height (m) was assessed using a stadiometer and body mass index (BMI) was

137

calculated in kg/m2. Physical activity was assessed by asking participants about their participation in regular

138

physical activities undertaken in the three months prior to their baseline visit [33]. Activity levels (kJ/d) were

139

calculated using a validated method, taking into consideration the type of activity, time engaged in the activity,
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140

and body weight[34]. Total energy intakes were estimated from the FFQ. Prevalent cancer and atherosclerotic

141

vascular disease (ASVD) at baseline was determined from primary discharge diagnoses from hospital records

142

(1980–1998). ICD codes for prevalent cancer included (ICD-9-CM codes C00-C99). ICD codes for prevalent

143

ASVD included: ischemic heart disease (ICD-9-CM codes 410–414); heart failure (ICD-9-CM code 428);

144

cerebrovascular disease excluding hemorrhage (ICD-9-CM codes 433–438); and peripheral arterial disease

145

(ICD-9-CM codes 440–444). Participants provided their previous medical history and current medications, with

146

this information verified by their General Practitioner where possible. These data were coded using the

147

International Classification of Primary Care – Plus (ICPC-Plus) method[35], allowing for aggregation of

148

different terms for similar pathologic entities as defined by the ICD-10 coding system, and then used to

149

determine the presence of diabetes at baseline.

150

Statistical Analysis

151

Analyses were undertaken using STATA/IC® 14.2 (StataCorp LLC), SAS® 9.4 (SAS Institute Inc) and R®

152

statistics (R Core Team[36]). Statistical significance was set at p≤0.05 (two-tailed) for all tests. For all analyses,

153

two models of adjustment were fit: 1) minimally-adjusted: age and energy intake; and 2) multivariable-adjusted:

154

age, energy intake, treatment code (calcium or placebo), BMI, smoking status, physical activity, alcohol intake,

155

diabetes status, use of antihypertensive medication, prevalent ASVD, statin use, and use of NSAIDs for joint

156

pain. Generalized additive models were used to examine the association between DII and both baseline eGFR

157

and the trajectory of eGFR change over the 10 years of follow-up. In the latter analysis, the time-points at which

158

eGFR was measured was adjusted for. The associations of DII with biomarkers of inflammation, eGFR, and the

159

trajectory of eGFR change were assessed by linear regression. Potential nonlinear relationships between DII and

160

renal disease-related mortality and hospitalisation events were examined using restricted cubic splines, with

161

hazard ratios (HRs) based on Cox proportional hazards models. HRs with 95% confidence intervals (CIs) were

162

plotted for each unit of the exposure against the median DII score in quintile 1. Age- and multivariable-adjusted

163

Cox proportional hazard ratios (HR) and 95% confidence intervals (CIs) for renal events were computed across

164

quintiles of DII score, where the lowest (least inflammatory) quintile was the referent. Schoenfeld residuals were

165

used to check the Cox proportional hazards assumptions, with no evidence of violation of this assumption. As

166

the research question addressed in this paper was aetiological in nature, we did not apply a sub-distribution

167

proportional hazards model to take into account competing risks[37]. Individuals who died or were lost to

168

follow-up were censored. As a sensitivity analysis, all participants with a history of cancer at baseline were

169

excluded and 1,336 were re-analysed. Statistical power was too limited to perform analysis for renal disease-
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170

related hospitalisation and deaths separately (114 renal disease-related hospitalisations and 19 renal disease-

171

related deaths).

172

Results

173

Baseline characteristics

174

In this population of 1,422 postmenopausal women, DII scores were normally distributed with a mean of 0.19

175

units and a SD of 2.14 units. The baseline characteristics of the study population, overall and stratified by DII

176

score quintiles [Q1 (-6.14, -1.72); Q2 (-1.73, - 0.38); Q3 (-0.39, 0.76); Q4 (0.77, 2.13); Q5 (2.14, 6.39)], are

177

shown in Table 1. At baseline, subjects in the highest versus the lowest quintile of DII score had a lower energy

178

intake, lower level of physical activity and lower eGFR. No other baseline characteristics appeared to differ

179

across the DII quintiles. Baseline intakes of dietary components that were used to calculate the DII score, for the

180

total cohort population and stratified by the occurrence of a renal disease-related event, are presented in

181

Supplemental Table 1. Intakes of trans-fatty acids were higher in participants who suffered from a renal event

182

(p=0.01). Intakes of the vitamins riboflavin, niacin, folate and vitamin E, the minerals iron, magnesium and

183

zinc, and isoflavones (from sources other than tea) were lower in participants who had experienced a renal event

184

(p<0.05 for all). Differences in baseline dietary intakes across DII quintiles are presented in Supplemental

185

Table 2. After energy adjustment, with the exception of alcohol, retinol equivalents, and garlic, intakes of all

186

other food parameters used to calculate the DII score were significantly different across DII quintiles (p<0.05).

187

Aside from carbohydrates and iron, the intakes of food parameters that positively contribute to the DII score

188

increased as DII quintiles increased while all food parameters that negatively contributed to the DII score

189

decreased across DII quintiles.

190

Associations between DII and renal function estimates

191

Of 1,111 participants with eGFR measured at baseline, the mean ± SD for eGFR was 65.9 ± 12.9

192

mL/min/1.73m2. Evidence for a linear association between DII score and baseline eGFR can be seen in Figure 2

193

(p=0.01). After multivariable adjustments a one-unit higher DII score was associated with a 0.55

194

mL/min/1.73m2 lower eGFR at baseline (p=0.01; Table 2). Of the 1,342 participants still alive after 5 years of

195

follow-up, eGFR was measured in 1,022; the mean ± SD for eGFR was 61.33 ± 14.19 mL/min/1.73m2. Of the

196

1,253 participants still alive after 10 years of follow-up, eGFR was measured in 738; the mean ± SD for eGFR

197

was 60.4 ± 15.8 mL/min/1.73m2. The association between DII score and eGFR at both 5 and 10 years was linear
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198

(p<0.01). After multivariable adjustments a one-unit higher DII score was associated with a 0.89

199

mL/min/1.73m2 lower eGFR at 5 years (p<0.01) and a 0.92 mL/min/1.73m 2 lower eGFR at 10 years (p=0.01;

200

Table 2). eGFR was calculated at two or more time points in 998 women, allowing for an estimation of renal

201

function trajectory (annual rate of change in eGFR) in this subgroup. Figure 3 provides weak evidence that

202

there is a linear association between DII and renal function trajectory (p=0.08). After multivariable adjustments

203

a one-unit higher DII score was associated with a 0.06 mL/min/1.73m2 greater annual decline in eGFR (p=0.05;

204

Table 2).

205

Associations between DII and biomarkers of inflammation

206

After multivariable adjustments, a one-unit higher DII score was associated with a 0.46 µmol/L higher baseline

207

plasma tHcy (p<0.001; Supplementary Table 3). DII score was not significantly associated with baseline levels

208

of hs-CRP (p=0.57; Supplementary Table 3).

209

Associations with 10-year renal disease-related events

210

During 13,013 person-years of follow-up (median follow-up time = 10 years), 123 (8.6%) participants

211

experienced a renal disease-related event (hospitalization or death). Restricted cubic splines provide evidence of

212

a non-linear association between baseline DII score and risk of a renal disease-related event (p for non-linearity

213

= 0.04; Figure 4). Compared to participants with a DII score of -2.6, those with a score >4 had a significantly

214

higher risk of experiencing a renal disease-related event (HR: 2.35, 95% CI: 1.16, 4.75). Minimal- and

215

multivariable-adjusted associations between DII score and renal events are shown in Table 3. After

216

multivariable adjustments, there was evidence that participants in the highest (most pro-inflammatory) quintile

217

of DII score were at a higher risk of experiencing a renal disease-related event (HR: 2.06, 95% CI: 0.97, 4.37)

218

compared to those in the lowest quintile.

219

Sensitivity analysis

220

Excluding participants with a history of cancer at baseline (n=86) did not change the main findings of the study.

221

After multivariable adjustments, a one-unit higher DII score was associated with a 0.57 mL/min/1.73m 2 (95%

222

CI: 0.13, 1.01, p=0.01) lower eGFR at baseline and a 0.06 mL/min/1.73m 2 (95% CI: 0.00, 0.12, p=0.05) greater

223

annual decline in eGFR. Furthermore, participants in the highest quintile of DII score had a two times higher

10

224

risk of experiencing a renal disease-related event (HR: 2.00, 95% CI: 0.973 4.28) compared to those in the

225

lowest quintile.

226

Discussion

227

The relationships between the inflammatory potential of the diet, assessed using the DII, renal function and

228

renal disease-related events were investigated in a cohort of 1,422 postmenopausal women. Evidence suggests

229

that participants with a higher pro-inflammatory diet score had poorer renal function and a greater decline in

230

renal function over 10 years of follow-up. Additionally, participants with high DII® score appeared to be at the

231

highest risk of a renal disease-related event.

232

Diet is an important and potentially easily modifiable risk factor for chronic disease[38]. A Western-style diet,

233

characterized by a high intake of added sugar, red meat, refined grains, and high-fat dairy products, contributes

234

to systemic inflammation (with elevated inflammatory biomarkers)[11] and development of CKD[12].

235

Conversely, a Mediterranean-style diet, characterized by a high intake of fruits, vegetables and wholegrains with

236

a low intake of red meats and saturated fat, attenuates systemic inflammation[39] and may be protective against

237

the development of CKD[40]. Although the DII score is used to reflect the overall inflammatory potential of the

238

participants’ diets, the relationship between specific food components included in the calculation of the DII and

239

renal disease events is more difficult to establish. However, women who experienced renal disease-related

240

events had higher intakes of pro-inflammatory trans-fatty acids, a dietary component characteristic of a

241

Western-style diet. Additionally, the intakes of anti-inflammatory dietary components including vitamins

242

(riboflavin, niacin, folate and vitamin E), minerals (iron, magnesium and zinc), and isoflavones were lower in

243

women who had experienced renal disease-related events.

244

Reduced kidney function has been shown to be an independent risk factor for cardiovascular disease and all-

245

cause mortality in the general population, with the risk of end-stage kidney disease increasing exponentially

246

with eGFR below 60 mL/min/1.73m2[4,41,42]. Although the association between CKD and mortality is well

247

recognized, the extent of a direct causal pathway remains unclear, since considerable indirect effects exist via an

248

excess of traditional CVD risk factors. Reduced kidney function is associated with significantly higher serum

249

levels of inflammatory biomarkers [43,44]. In addition, the DII score is positively associated with circulating

250

levels of the inflammatory biomarkers, CRP [45,46] and IL-6 [45,47,46,21], suggesting the likelihood of an

251

inverse association between DII and kidney function. In the present study, participants with a higher DII score

11

252

had a lower eGFR at baseline, suggesting that a pro-inflammatory diet is associated with poorer kidney function.

253

In line with our findings, recent cross-sectional studies have reported that a higher DII score was associated with

254

worse kidney function, a higher prevalence of CKD [48], and, in participants with CKD, a higher risk of being

255

in a later stage of CKD [49]. In a cross-sectional study of 1,942 elderly Swedish men and women, from two

256

independent cohorts, researchers considered the association between an adapted DII (ADII) and kidney

257

function[6]. The ADII differs from the DII used in this paper in that it is calculated by modifying an older

258

version of the DII which uses fewer dietary parameters, is based on reviewing less articles (n=927) and is now

259

obsolete for reasons described elsewhere [50]. Despite the methodologic deficiencies, the authors demonstrated

260

that a 1 SD higher ADII score was associated with a 1.8% lower eGFR at baseline (β: −1.8%; 95% CI: −2.7%,

261

−0.9%; p< 0.001). Mediation analyses revealed that 15% of the association could be explained by increased

262

plasma levels of CRP. Whether dietary changes to incorporate more anti-inflammatory foods can improve renal

263

function warrants further investigation.

264

Temporal change in eGFR may be a more accurate prediction of adverse long-term health outcomes in the

265

general population compared to a single-time-point eGFR. In a study of 4,380 subjects with 7-year follow-up,

266

individuals who had experienced a more rapid loss of kidney function, greater than 3 ml/min/1.73m2, were at

267

more than a 50% higher risk of death and developing CVD, independent of baseline eGFR and traditional CVD

268

risk factors [51]. In a comparable population, consisting primarily of older white women, a Western-style

269

dietary pattern correlated directly with a rapid decline of eGFR [52]. To our knowledge, no previous studies

270

have examined the relationship between DII and renal function decline. Our results show that participants with

271

the most pro-inflammatory diet had the lowest eGFR at each time-point and experienced the greatest decline in

272

renal function over 10 years.

273

To date, no previous prospective cohort study has examined the relationship between DII and renal disease-

274

related events. Our results suggest that the risk of a renal disease-related event is highest in participants with the

275

most pro-inflammatory diet. However, our findings of a non-linear association suggest that only individuals

276

with a highly pro-inflammatory diet are at a higher risk. If this proposed association is confirmed to be causal,

277

individuals at the upper end of the DII score scale should be the primary target for dietary intervention, as they

278

are likely to experience the most benefit. With projected expenditures of renal disease-related disease reaching

279

12 billion AUD by 2020 [2], such findings are of great clinical and economic significance.
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280

There are a number of strengths of this study, including the use of a large prospective cohort of subjects with no

281

loss to follow-up, combined with use of the literature-derived DII, validated against a variety of inflammatory

282

markers [45,47,46,21], and the use of an eGFR equation based on creatinine and cystatin C which is a better

283

measure of true GFR than eGFR equations using creatinine alone [53]. Renal disease-related events were

284

ascertained through independently reported hospital records, removing the risk of recall bias. Furthermore,

285

adjusting for a large number of potential confounding factors did not significantly alter the observed relationship

286

between DII and eGFR. The strengths of this study must be balanced against the limitations; firstly this is an

287

observational study and as such causality cannot be established. Secondly, the findings are in a cohort of women

288

of European descent aged ≥ 70 years with adequate nutrition, therefore limiting the ability to generalize findings

289

to males, other ethnic groups, younger individuals, and those with poor nutrition intakes. Participant DII scores

290

could only be calculated from 32 of the original 45 dietary components that were available from the FFQ used in

291

the PLSAW study. Participants only completed an FFQ at baseline meaning that changes in DII scores over time

292

were not able to be assessed. Additionally, the modest number of event cases resulted in the inability to assess

293

the risk of renal disease hospitalization and mortality separately.

294

Conclusion

295

In the present cohort of women ≥70 years of age, we have shown that a pro-inflammatory dietary pattern,

296

reflected by a higher DII score, is associated with poorer renal function, a more rapid renal function decline over

297

10 years, and a higher risk of renal disease-related hospitalization and/or death. Further research is warranted to

298

confirm the association between the inflammatory potential of the diet and kidney function as well as to verify

299

these findings in other population groups.
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Table 1. Baseline characteristics of study population
Total population
n=1422

DII® quintiles
Q2
n=284
-1.02 [-1.73, -0.38]

Q3
n=283
0.18 [-0.39, 0.76]

Q4
n=287
1.40 [0.77, 2.13]

Q5
n=285
3.18 [2.14, 6.39]

P value

0.19 [-6.14, 6.39]

Q1
n=283
-2.83 [-6.14, -1.72]

75.2 ± 2.7

75.3 ± 2.7

75.0 ± 2.7

75.3 ± 2.7

75.2 ± 2.7

75.1 ± 2.8

0.69

Body mass index (kg/m )

27.2 ± 4.8

27.2 ± 4.8

27.0 ± 4.3

27.3 ± 4.6

27.5 ± 4.8

26.9 ± 5.1

0.77

Energy intake (MJ/d)

7.1 ± 2.1

9.2 ± 2.0

7.7 ± 1.7

7.0 ± 1.4

6.1 ± 1.4

5.4 ± 1.4

<0.001

Smoked ever, n (%)

530 (37.2)

107 (37.8)

103 (36.3)

96 (33.9)

106 (36.9)

118 (41.4)

0.53

470 [114, 857]

554 [213, 901]

488 [219, 906]

469 [0, 800]

464 [100, 850]

354 [0, 795]

0.004

0.8 [0.3, 9.8]

1.4 [0.1, 12.9]

2.0 [0.4, 9.9]

2.2 [0.3, 9.3]

1.9 [0.3, 9.8]

1.1 [0.2, 8.0]

0.34

84 (5.9)

16 (5.7)

18 (6.3)

13 (4.6)

20 (7.0)

17 (6.0)

0.78

163 (11.4)

32 (11.3)

25 (8.8)

37 (13.1)

38 (13.2)

31 (10.9)

0.44

86 (6.0)

14 (4.9)

11 (3.9)

25 (8.8)

19 (6.6)

17 (6.0)

0.14

65.9 ± 12.8

67.0 ± 12.1

67.5 ± 13.2

64.1 ± 12.9

65.8 ± 12.9

65.2 ± 12.9

0.03

Treatment (calcium)

744 (52.3)

157 (55.5)

154 (54.2)

152 (53.7)

140 (48.8)

141 (49.1)

0.54

Antihypertensive

612 (43.0)

126 (44.5)

141(49.6)

131 (46.3)

123 (42.9)

121 (49.5)

0.59

NSAIDs for joint pain

469 (33.0)

87 (30.7)

95 (33.5)

101 (35.7)

89 (31.0)

97 (34.0)

0.66

Statins

269 (18.9)

67 (23.7)

52 (18.3)

52 (18.4)

45 (15.7)

53 (18.6)

0.13

DII, mean [range]
Demographics
Age (years)
2

Physical activity (kJ/day), median
[IQR]
Alcohol intake (g/d), median [IQR]
Diabetes, n (%)
ASVD, n (%)
Cancer, n (%)
2

eGFR (mL/min per 1.73m )
Medications, n (%)

®

2

Data expressed as mean ± SD unless otherwise stated. P-values for comparisons between DII score quintiles were derived by ANOVA, Kruskal-Wallis H test or x test where appropriate.
ASVD, atherosclerotic vascular disease; DII®, Dietary Inflammatory Index; eGFR, estimated Glomerular Filtration Rate.
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Table 2. Association between DII score and eGFR at baseline (1998), 5 years (2003), and 10 years (2008) and annual rate of
change in eGFR.
N
Model 1
Model 2
β (95% CI)
p value
β (95% CI)
p value
eGFR at baseline
1,111
-0.49 (-0.94, -0.05)
0.03
-0.55 (-0.98, -1.22)
0.01
eGFR at 5 years
1,022
-0.82 (-1.34, -0.30)
<0.01
-0.89 (-1.38, -0.39)
<0.01
eGFR at 10 years
738
-0.80 (-1.51, -0.08)
0.03
-0.92 (-1.60, -0.24)
0.01
Annual change in eGFR*
998
-0.06 (-0.12, 0)
0.07
-0.06 (-0.12, 0)
0.05
Association between baseline dietary inflammatory index (DII®) score and estimated glomerular filtration rate (eGFR) at
baseline, 5 years and 10 years of follow-up, and annual rate of change in eGFR. Estimates were obtained using linear regression
analyses adjusted for age and energy (Model 1) and age, energy intake, treatment code, BMI, smoking status, physical activity,
alcohol intake, diabetes status, use of antihypertensive medication, prevalent ASVD, statin use, and use of NSAIDs for joint pain
(Model 2). *Adjusted for years in which eGFR was measured.

Table 3. Risk estimates of renal disease-related events during 10 years of follow-up
N (events/total)
Model 1
Model 2
HR (95% CI)
p value
HR (95% CI)
p value
Baseline DII quintiles
Q1 (<-1.72)
18/283
1.00 (Referent)
1.00 (Referent)
Q2 (-1.73, -0.38)
23/284
1.35 (0.71, 2.56)
0.36
1.35 (0.70, 2.58)
0.37
Q3 (-0.39, 0.76)
27/283
1.53 (0.80, 2.93)
0.20
1.51 (0.78, 2.93)
0.22
Q4 (0.77, 2.13)
22/287
1.18 (0.57, 2.43)
0.65
1.12 (0.54, 2.33)
0.77
Q5 (≥2.14)
33/285
1.96 (0.95, 4.05)
0.07
2.06 (0.97, 4.37)
0.06
DII, Dietary inflammatory index.
Hazard rations (HR) and 95% confidence intervals (CI) were obtained from Cox proportional hazards models adjusted for age and
energy (Model 1) and age, energy intake, treatment code, BMI, smoking status, physical activity, alcohol intake, diabetes status,
use of antihypertensive medication, prevalent ASVD, statin use, and use of NSAIDs for joint pain (Model 2).
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Figure Legends:
Fig. 1 Consort flow diagram.; eGFR, estimated glomerular filtration rate; FFQ, food frequency questionnaire

Fig. 2 Graphic presentation of the multivariable adjusted effect of dietary inflammatory index (DII) on estimated
glomerular filtration rate (eGFR) in 1,111 elderly Western Australian women at baseline (1998). The vertical axis
is the difference in eGFR at each DII score relative to the eGFR for the mean DII score. The association was
obtained from a generalized additive model adjusted for age, energy intake, treatment code, BMI, smoking status,
physical activity, alcohol intake, diabetes status, use of antihypertensive medication, prevalent ASVD, statin use,
and use of NSAIDs for joint pain.

Fig. 3 Graphic presentation of the multivariable adjusted effect of dietary inflammatory index (DII) on annual rate
of change of estimated glomerular filtration rate (eGFR; p=0.08) in 998 elderly Western Australian women during
10 years of follow-up (1998 - 2008). The vertical axis is the difference in the annual rate of change of eGFR at
each DII score relative to the annual rate of change of eGFR for the mean DII score. The association was obtained
from a generalized additive model adjusted for age, energy intake, treatment code, BMI, smoking status, physical
activity, alcohol intake, diabetes status, use of antihypertensive medication, prevalent ASVD, statin use, use of
NSAIDs for joint pain, and time of eGFR measurements.

Fig. 4 Cubic spline curves describing the association between Dietary Inflammatory Index score and renal diseaserelated events (hospitalization or death); p for non-linearity = 0.04. Hazard ratios are based on Cox proportional
hazards models adjusted for age, energy intake, treatment code, BMI, smoking status, physical activity, alcohol
intake, diabetes status, use of antihypertensive medication, prevalent ASVD, statin use, use of NSAIDs for joint
pain, and are comparing the specific Dietary Inflammatory Index score (horizontal axis) to the median score for
participants in the quintile 1 (-2.6)
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Figure 1. Consort flow diagram.; eGFR, estimated glomerular filtration rate; FFQ, food
frequency questionnaire.
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Figure 2. Graphic presentation of the multivariable adjusted effect of dietary inflammatory
index (DII) on estimated glomerular filtration rate (eGFR) in 1,111 elderly Western Australian
women at baseline (1998). The vertical axis is the difference in eGFR at each DII score relative
to the eGFR for the mean DII score. The association was obtained from a generalized additive
model adjusted for age, energy intake, treatment code, BMI, smoking status, physical activity,
alcohol intake, diabetes status, use of antihypertensive medication, prevalent ASVD, statin use,
and use of NSAIDs for joint pain.
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Figure 3. Graphic presentation of the multivariable adjusted effect of dietary inflammatory
index (DII) on annual rate of change of estimated glomerular filtration rate (eGFR; p=0.08) in
998 elderly Western Australian women during 10 years of follow-up (1998 - 2008). The
vertical axis is the difference in the annual rate of change of eGFR at each DII score relative to
the annual rate of change of eGFR for the mean DII score. The association was obtained from
a generalized additive model adjusted for age, energy intake, treatment code, BMI, smoking
status, physical activity, alcohol intake, diabetes status, use of antihypertensive medication,
prevalent ASVD, statin use, use of NSAIDs for joint pain, and time of eGFR measurements.
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Figure 4. Cubic spline curves describing the association between Dietary Inflammatory Index
score and renal disease-related events (hospitalization or death); p for non-linearity = 0.04.
Hazard ratios are based on Cox proportional hazards models adjusted for age, energy intake,
treatment code, BMI, smoking status, physical activity, alcohol intake, diabetes status, use of
antihypertensive medication, prevalent ASVD, statin use, use of NSAIDs for joint pain, and
are comparing the specific Dietary Inflammatory Index score (horizontal axis) to the median
score for participants in the quintile 1 (-2.6).
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